Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Polyethylene Glycol 1000, or PEG 1000, falls into the family of polyether compounds often relied on in pharmaceutical, food, and cosmetic manufacturing. You won’t often see PEG 1000 in its pure state unless you work in a lab or manufacturing facility, but its presence affects countless daily essentials. Produced by polymerizing ethylene oxide, this compound sits in the lower-molecular-weight range for polyethyleneglycols, which shapes both its chemical and physical behavior. The recognition as BP, EP, and USP grade means it meets stringent British, European, and United States Pharmacopeia benchmarks. No ordinary ingredient, it shapes drug solubility, shelf stability, and consistency, and its versatility reflects decisions across supply chains.
Bearing the chemical formula C2nH4n+2On+1, PEG 1000 sports a molecular weight close to 950-1050 g/mol, depending on batch and supplier. Density hovers around 1.1 g/cm³ at room temperature, which makes it neither too light for fast movement on conveyors, nor so heavy as to strain handling equipment. As a solid at standard temperatures, PEG 1000 appears in forms such as coarse or fine flakes, pearls, powder, or even compressed slabs and bars. If left in the hand, it feels waxy and slips easily between fingers, dissolving in water or alcohol. In a pharmaceutical setting, its melting range—spanning from about 37 to 40°C—translates to a product that changes from solid to viscous liquid just above body temperature. Many in soap and cream production rely on that melting trait to create consistent textures. Its crystalline white look and neutral odor mean it won’t taint smells or colors of formulations, and careful sourcing avoids contaminants in medical use.
Every bulk shipment carries a Harmonized System code for customs—PEG 1000 typically travels under HS Code 39072090 as a polyether, cleared for international trade in industrial and pharma markets. Material certificates document conformity with BP, EP, and USP requirements. Each grade covers microbiological purity, heavy metal safety, and water content. Processes follow strict hazard protocols, but the end user gets a reliable product suitable not just for oral, topical, and injectable applications, but also for coatings or excipient roles. Pharmaceutical buyers insist on batch-to-batch reproducibility, and labs check for specific gravity, pH (commonly 4.5-7.5 in 5% solution), and viscosity before releasing to medicine makers.
Manufacturers turn out PEG 1000 as hard flakes, semi-solid masses, creamy blocks, and pelletized pearls. Each form solves a practical problem on factory floors. Flakes dissolve fast in warm liquids, reducing process times in heated mixers. Pearls feed evenly into tablet presses. Even as a powder or in softer, gelled forms, it spreads well without clumping or static issues. Further down the line, formulators exploit PEG 1000’s ability to solubilize hydrophobic drugs, soften suppositories, and lubricate tablets without triggering allergic or toxic reactions. In dental materials, it works as a humectant. In topical creams or ointments, it helps trap moisture in skin.
As a raw material, PEG 1000 doesn’t present high acute toxicity. The Environmental Protection Agency in the US and corresponding European agencies class it as practically non-hazardous when handled correctly. Inhalation of dust over extended periods could trigger slight respiratory irritation, but most production lines automate dispensing into sealed vessels. Workers don gloves and goggles not just for safety, but to avoid slipping in case of spillage. Once in a formulated product, PEG 1000 serves as a dependable carrier for active substances, with low rates of dermatitis or allergic response reported in medical literature. I’ve seen manufacturers prioritize documentation and traceability for this reason. Spills clean up with warm water, and any waste product usually falls under non-hazardous waste streams for routine disposal where local regulations approve.
Genuine pharma-grade PEG 1000 comes from properly audited factories that can verify origin and good manufacturing practices. Global events have shown that disruptions in ethylene oxide supply chains result in cost increases and delivery delays—affecting vaccine production, oral syrups, and ointments for hospitals. Trustworthy supply cuts down on costly recertifications and keeps hospitals and pharmacies stocked with basic but critical products. I’ve discussed ingredients like PEG 1000 with pharmacists who rely on consistent batches to keep essential medications and creams on the shelf, and with manufacturers who press purchasing teams to trace every lot and audit every supplier for compliance. These actions lower the risks of substitution, interruption, or chemical inconsistency.
No system is perfect, and any raw material system carries environmental and resource questions. The basic building block—ethylene oxide—comes from petrochemical sources, raising debates over long-term sustainable sourcing. Some researchers and companies now push for recycling waste PEG or exploring bio-based synthesis routes. Until those alternatives scale, responsible disposal and transparent supply chains serve as the key solutions. In years of seeing product batches go from lab to finished drugstore good, care at every checkpoint—from tanker delivery through lab testing—matters much more than marketing claims. Ongoing training, audit transparency, and small-scale adoption of greener pathways offer promise.
A reliable and industry-approved source of PEG 1000 sustains not only pharmaceuticals and personal care goods, but also a web of supporting jobs, logistics, and healthcare solutions. It promises stability, helps shape modern formulations, and enables efficiency across continents. Adhering to strong specification management, careful supplier selection, and real-world safety practices—while pushing for sustainable improvement—does more than keep products working. It promotes trust across the industry and can improve public and patient outcomes with every safe, predictable batch that reaches the people who rely on it.
Chengguan District, Lanzhou, Gansu, China
